Day: July 22, 2020

ST. LOUIS, July 22, 2020 (GLOBE NEWSWIRE) — A new Stifel Financial Corp. (NYSE: SF) survey of global technology executives and entrepreneurs finds that even though the business and economic impacts of COVID-19 are expected to linger, most respondents believe the worst is behind us.While a majority (60%) of survey respondents expect to feel some impact from COVID-19 for another six months or longer, more than half (53%) believe the worst is already over. Only 23% anticipate ending the year significantly under budget. In fact, roughly one-fifth (19%) now forecast better-than-expected financial performance.According to the survey, only 7% foresee a sharp, prolonged “L-shaped” recovery, which is a worst-case economic scenario. 60% of respondents anticipate a more moderate “U-shaped” recovery. Expectations among the rest are split between...

TORONTO, July 22, 2020 (GLOBE NEWSWIRE) — Claren Energy Corp. (“Claren” or the “Company”) (TSX-V: CEN) is pleased to announce a non-brokered private placement of up to 24,000,000 common shares of the Company (the “Shares”) at a price of CAD $0.05 per share for gross proceeds of up to CAD $1,200,000 (the “Private Placement”).All securities issued in connection with the Private Placement will be subject to a four-month hold period from the closing date under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada. Claren intends to use the proceeds from the Private Placement for general working capital purposes and to repay corporate indebtedness. Certain insiders of the Company may acquire shares under the Private Placement, and closing...

ALAMEDA, Calif., July 22, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NASDAQ: DZSI or the “Company” or “DZS”), a leading enabler of the emerging hyper-connected, hyper-broadband world, will hold a conference call on Wednesday, August 5, 2020 at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2020. Financial results will be issued in a press release prior to the call.DZS management will host the conference call, followed by a question and answer period.Date: Wednesday, August 5, 2020Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)U.S. dial-in number: 877-742-9182International number: 602-563-8857Conference ID: 5666023Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have...

JERSEY CITY, N.J., July 22, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of four posters at the American Society for Microbiology (ASM) Microbe 2020 held virtually from June through August. The posters, presented as part of the ASM Microbe Online 2020 Summer of Science program, now available online, highlight the potential clinical utility of ibrexafungerp. Ibrexafungerp is the first representative of a new class of antifungal agents called triterpenoids, which are broad-spectrum, fungicidal, and designated by the suffix “-fungerp”. Following the successful completion of its VANISH Phase 3 program, the Company plans to submit a new drug application (NDA) for...

 Stable topical composition has potential to reduce side effects of orally delivered compositions in treatment of acne and rosacea WOODCLIFF LAKE, NJ, July 22, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received notice from the European Patent Office (EPO) that it intends to grant a patent for the company’s topical composition of pharmaceutical tetracycline (including minocycline) for dermatological use (European Patent Application No. 16714168.8). In May 2020, Timber announced the closing of a merger with BioPharmX Corporation and its intention to evaluate BioPharmX’s Phase 3...

BOULDER, Colo., July 22, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced it will report its second quarter 2020 financial results after the financial markets close on Wednesday August 5, 2020.  The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Wednesday August 5, 2020. To access the call, please dial 877-407-0789 in the U.S. or 201-689-8562 outside the U.S. and provide the conference ID number: 13706539. To access the live webcast, please go to the investors section of miRagen’s website at http://investors.miragen.com/events. Following the live webcast, an archived version of the call will be available on the website.About miRagen Therapeutics,...

HERNDON, Va., July 22, 2020 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT) announced today that it has been awarded a five-year $87 million task order to provide advanced IT Software Research, Development and Engineering in support of the Navy Maritime Maintenance Enterprise Solution (NMMES) for the Naval Sea Systems Command (NAVSEA) ship maintenance mission.ManTech was awarded this contract under the Department of Defense Information Analysis Center’s (DoD IAC) Multiple Award Contract (MAC). DoD IAC MAC task orders are competitively awarded by the U.S. Air Force Installation Contracting Center (AFICC) for work at various U.S. military organizations.“ManTech has supported NAVSEA for 35 years across the full spectrum of engineering requirements, with more than 10 years of direct support to the public shipyards and ship maintenance organizations...